Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis
通过 TMS 和 EEG 绘制创伤后癫痫发生过程中皮质内抑制的逐渐丧失
基本信息
- 批准号:8888294
- 负责人:
- 金额:$ 36.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-01 至 2020-02-29
- 项目状态:已结题
- 来源:
- 关键词:AcetylcysteineAdultAnatomyAnimalsAntiepileptogenicAntioxidantsBiological AssayBiological MarkersBiological ProcessBrainBrain InjuriesCalcium-Binding ProteinsCeftriaxoneCellsCerebrumCessation of lifeClinicalClinical TrialsContralateralDataDepressed moodDetectionDevelopmentDiagnosticDiagnostic ProcedureElectroencephalographyEpilepsyEpileptogenesisFrequenciesFunctional disorderGlutamatesGoalsHarvestHealthHeterogeneityHumanIndividualInjuryInterneuronsInterventionLateralLeadLimb structureLiquid substanceMapsMeasuresMediatingMethodsModelingMotor CortexMotor Evoked PotentialsMuscleNeurologicOutcomeParvalbuminsPathologicPatientsPercussionPhysiologic pulsePost-Traumatic EpilepsyProcessProtocols documentationRattusResearch PersonnelRiskSeizuresSkinSorting - Cell MovementStimulusStress TestsTestingTimeTissuesTranscranial magnetic stimulationTranslatingTraumatic Brain InjuryWorkbaseconditioningfluid percussion injurygamma-Aminobutyric Acidimprovedinsightmagnetic fieldnew therapeutic targetoutcome forecastpreventprophylacticpublic health relevanceresearch studyresponsetoolyoung adult
项目摘要
DESCRIPTION (provided by applicant): Cerebral injury often leads to epilepsy via epileptogenesis, the process by which the brain is transformed into an enduring state (epilepsy) characterized by repeated unprovoked seizures. Severe traumatic brain injury (TBI) is the most common example of epiletogenesis in young adults, and leads to epilepsy in 20-50% of instances. This epileptogenic period provides a window of opportunity where patients at risk for developing seizures may be identified, and where anti-epileptogenic therapy may be administered. Yet, there is no reliable clinical biomarker for epileptogenesis to identify whether epileptogenesis has started and how far it has advanced. Accordingly, the long-term goal of the proposed experiments is to use a rat epileptogenic TBI model to develop a safe, inexpensive and noninvasive electrophysiologic biomarker of epileptogenesis that is based on measures of cortical excitability by transcranial magnetic stimulation (TMS). As a secondary goal, we will test
if similar measures can be obtained by cortical EEG. We recently developed methods for focal motor cortex TMS in rats, demonstrated that these reliably reflect the magnitude of GABA-mediated cortical inhibition, and showed that such inhibition is depressed in rat seizure models, including a model of posttraumatic epilepsy. Here we propose to use the rat lateral fluid percussion (LFP) possttraumatic epilepsy model to test (1) whether the loss of cortical inhibition is progressive in time during epileptogenesis, (2) whether loss of intracortical inhibition after injury can predict seizure onset, and (3) whether potentially reversible cellular changes such as loss of GABA-ergic interneurons underlie the TMS-derived measures of cortical inhibition loss. Although the proposed experiments are limited to a rat model of post-TBI epileptogenesis, we anticipate that the results will inform studies of TMS as a biomarker in other forms of epileptogenesis. Further, as we will record EEG in all animals, we will test whether gamma frequency EEG power, which also reflects the integrity of GABA-mediated cortical inhibition, can serve as an epileptogenesis biomarker. Since TMS and EEG are already in wide human use, we anticipate that favorable data from the proposed experiments will be rapidly translated to clinical trials in human TBI.
描述(由申请人证明):脑损伤通常导致TOA癫痫发生,N持续状态(癫痫)的过程以重复未证实的癫痫发作为特征可以识别出有癫痫发作的癫痫病,并且抗癫痫病疗法可能会鉴定出癫痫发作支撑的经验用于开发癫痫生成的安全,廉价的电物质,该电源基于经颅磁刺激(TMS)的皮质兴奋性测量。
如果可以通过皮质脑电图获得类似的措施,我们最近开发了大鼠焦点TMS的方法,反映了GABA介导的皮质抑制作用的大幅度,并表明这种厌食症,包括创伤后抑制作用的模型。在癫痫发生过程中,(2)丧失心脏内部损伤是否可以预测癫痫发作,以及(3)潜在的CERLAR是否会改变GABA-RGIC中间神经元的屁股,尽管提出的实验是皮质抑制的TMS衍生的ES。限于TBI癫痫发生的大鼠模型可以迅速转化为人类TBI的临床试验。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alexander Rotenberg其他文献
Alexander Rotenberg的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alexander Rotenberg', 18)}}的其他基金
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
开发用于琥珀半醛脱氢酶缺乏症 (SSADHD) 基因替代疗法的诱导小鼠模型
- 批准号:
10544054 - 财政年份:2022
- 资助金额:
$ 36.92万 - 项目类别:
Developing an inducible mouse model for gene replacement therapy in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)
开发用于琥珀半醛脱氢酶缺乏症 (SSADHD) 基因替代疗法的诱导小鼠模型
- 批准号:
10380224 - 财政年份:2022
- 资助金额:
$ 36.92万 - 项目类别:
Astrocytic Glutamate Transporter 1 (GLT-1) enhancement for the treatment of seizures in Dravet Syndrome
星形细胞谷氨酸转运蛋白 1 (GLT-1) 增强治疗 Dravet 综合征癫痫发作
- 批准号:
10288936 - 财政年份:2021
- 资助金额:
$ 36.92万 - 项目类别:
Neurophysiologic investigation of somatosensory dysfunction in Autism Spectrum Disorders
自闭症谱系障碍体感功能障碍的神经生理学研究
- 批准号:
10057023 - 财政年份:2020
- 资助金额:
$ 36.92万 - 项目类别:
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis
通过 TMS 和 EEG 绘制创伤后癫痫发生过程中皮质内抑制的逐渐丧失
- 批准号:
9215704 - 财政年份:2015
- 资助金额:
$ 36.92万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7390304 - 财政年份:2007
- 资助金额:
$ 36.92万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7613431 - 财政年份:2007
- 资助金额:
$ 36.92万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
8062000 - 财政年份:2007
- 资助金额:
$ 36.92万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7209565 - 财政年份:2007
- 资助金额:
$ 36.92万 - 项目类别:
Antiepileptogenesis by Transcranial Magnetic Stimulation
经颅磁刺激抗癫痫发生
- 批准号:
7805495 - 财政年份:2007
- 资助金额:
$ 36.92万 - 项目类别:
相似国自然基金
单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
- 批准号:82373465
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
- 批准号:82300208
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
- 批准号:82372499
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Mapping brain glutamate in humans: sex differences in cigarette smokers
绘制人类大脑谷氨酸图谱:吸烟者的性别差异
- 批准号:
10376214 - 财政年份:2021
- 资助金额:
$ 36.92万 - 项目类别:
NINDS CREATE DISCOVERY: Development of dendrimer-N-acetylcysteine for the treatment of neonatal brain injury
NINDS 创造发现:开发用于治疗新生儿脑损伤的树枝状聚合物-N-乙酰半胱氨酸
- 批准号:
9906957 - 财政年份:2018
- 资助金额:
$ 36.92万 - 项目类别:
Mapping progressive loss of intracortical inhibition by TMS and EEG in posttraumatic epileptogenesis
通过 TMS 和 EEG 绘制创伤后癫痫发生过程中皮质内抑制的逐渐丧失
- 批准号:
9215704 - 财政年份:2015
- 资助金额:
$ 36.92万 - 项目类别:
Nanotherapies for the treatment of neurodevelopmental disorders.
用于治疗神经发育障碍的纳米疗法。
- 批准号:
8671529 - 财政年份:2014
- 资助金额:
$ 36.92万 - 项目类别: